Oncology & Cancer

Four reasons I won't have a prostate cancer blood test

Cancer Council Australia and the Prostate Cancer Foundation of Australia yesterday released new draft guidelines to help GPs counsel men who ask about prostate cancer tests. They advise GPs to explain the pros and cons of ...

Oncology & Cancer

New approach to prostate cancer screening needed, expert says

(Medical Xpress)—The UK needs to invest in testing for those men most at risk of prostate cancer rather than follow a cast-the-net-wide approach targeting the whole population, a leading scientist from The University of ...

Oncology & Cancer

Many men not told pros, cons of PSA testing, survey finds

(HealthDay)—Many doctors insulate their patients from the complexities surrounding the PSA test, and instead decide on their own whether to screen for prostate cancer or not, a new study finds.

Oncology & Cancer

New prostate cancer test could change treatment

Thousands of men face a prostate biopsy following higher-than-normal results from their annual prostate-specific antigen (PSA) test, the traditional screening for prostate cancer. But recent studies have shown three in four ...

Oncology & Cancer

Expert panel suggests PSA test may benefit some men

(HealthDay) -- Men with a life expectancy of more than 10 years should talk with their doctor about getting a prostate-specific antigen (PSA) test for prostate cancer, an expert panel recommends.

Oncology & Cancer

Final advice: Panel against routine prostate test

Healthy men shouldn't get routine prostate cancer screenings, says updated advice from a government panel that found the PSA blood tests do more harm than good.

Oncology & Cancer

A new screening method for prostate cancer

A new study by NYU Langone Medical Center and Northwestern University Feinberg School of Medicine shows novel PSA velocity (PSAV) risk count testing may provide a more effective way for physicians to screen men for clinically ...

page 3 from 4